Cargando…

Therapeutic Targeting of the Gas6/Axl Signaling Pathway in Cancer

Many signaling pathways are dysregulated in cancer cells and the host tumor microenvironment. Aberrant receptor tyrosine kinase (RTK) pathways promote cancer development, progression, and metastasis. Hence, numerous therapeutic interventions targeting RTKs have been actively pursued. Axl is an RTK t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Mai, Siemann, Dietmar W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469858/ https://www.ncbi.nlm.nih.gov/pubmed/34576116 http://dx.doi.org/10.3390/ijms22189953

Ejemplares similares

Gas6/Axl Signaling Pathway in the Tumor Immune Microenvironment
por: Tanaka, Mai, et al.
Publicado: (2020)

Axl signaling is an important mediator of tumor angiogenesis
por: Tanaka, Mai, et al.
Publicado: (2019)

Inhibition of the Axl pathway impairs breast and prostate cancer metastasis to the bones and bone remodeling
por: Tanaka, Mai, et al.
Publicado: (2021)

Gas6/AXL pathway: immunological landscape and therapeutic potential
por: Zhai, Xiaoqian, et al.
Publicado: (2023)

Testosterone ameliorates vascular aging via the Gas6/Axl signaling pathway
por: Chen, Yan-Qing, et al.
Publicado: (2020)

Stromal cells in breast cancer as a potential therapeutic target
por: Dykes, Samantha S., et al.
Publicado: (2018)

Macrophage phenotypes and Gas6/Axl signaling in apical lesions
por: Chen, Szu-Yu, et al.
Publicado: (2019)

AXL/Gas6 signaling mechanisms in the hypothalamic-pituitary-gonadal axis
por: Mohammadzadeh, Pardis, et al.
Publicado: (2023)

Gas6/Axl in arginine-starvation therapy
por: Tsai, Wen-Bin, et al.
Publicado: (2015)

A Functional Role of GAS6/TAM in Nonalcoholic Steatohepatitis Progression Implicates AXL as Therapeutic Target
por: Tutusaus, Anna, et al.
Publicado: (2019)

AXL in cancer: a modulator of drug resistance and therapeutic target
por: Tang, Yaoxiang, et al.
Publicado: (2023)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

Targeting AXL in NSCLC
por: Zaman, Aubhishek, et al.
Publicado: (2021)

AXL receptor tyrosine kinase as a therapeutic target in NSCLC
por: Okimoto, Ross A, et al.
Publicado: (2015)

Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis
por: Bellomo, Gaia, et al.
Publicado: (2022)

Immunological Aspects of AXL/GAS‐6 in the Context of Human Liver Regeneration
por: Ortmayr, Gregor, et al.
Publicado: (2021)

AXL as a Target in Breast Cancer Therapy
por: Colavito, Sierra A.
Publicado: (2020)

Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth
por: Lechertier, Tanguy, et al.
Publicado: (2020)

NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway
por: Fang, Shanyu, et al.
Publicado: (2021)

AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
por: Falcone, Italia, et al.
Publicado: (2020)

AXL kinase as a novel target for cancer therapy
por: Wu, Xiaoliang, et al.
Publicado: (2014)

Endocytic trafficking of GAS6–AXL complexes is associated with sustained AKT activation
por: Poświata, Agata, et al.
Publicado: (2022)

Corosolic Acid Attenuates the Invasiveness of Glioblastoma Cells by Promoting CHIP-Mediated AXL Degradation and Inhibiting GAS6/AXL/JAK Axis
por: Sun, Li-Wei, et al.
Publicado: (2021)

Gas6 Inhibits Toll-Like Receptor-Mediated Inflammatory Pathways in Mouse Microglia via Axl and Mer
por: Gilchrist, Shannon E., et al.
Publicado: (2020)

Gas6 Attenuates Sepsis-Induced Tight Junction Injury and Vascular Endothelial Hyperpermeability via the Axl/NF-κB Signaling Pathway
por: Ni, Jingjing, et al.
Publicado: (2019)

Neuroprotective Effects of Omentin-1 Against Cerebral Hypoxia/Reoxygenation Injury via Activating GAS6/Axl Signaling Pathway in Neuroblastoma Cells
por: Niu, Xiaochen, et al.
Publicado: (2022)

PRAME Is a Novel Target of Tumor-Intrinsic Gas6/Axl Activation and Promotes Cancer Cell Invasion in Hepatocellular Carcinoma
por: Hedrich, Viola, et al.
Publicado: (2023)

Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
por: Gustafsson, Anna, et al.
Publicado: (2009)

AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
por: May, Caitlin D., et al.
Publicado: (2015)

GAS6/Axl Signaling Modulates Blood-Brain Barrier Function Following Intravenous Thrombolysis in Acute Ischemic Stroke
por: Guo, Zhen-Ni, et al.
Publicado: (2021)

Author Correction: Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth
por: Lechertier, Tanguy, et al.
Publicado: (2023)

Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3β/β-catenin Signaling
por: Wang, Cun, et al.
Publicado: (2016)

Gas6/Axl signaling attenuates alveolar inflammation in ischemia-reperfusion-induced acute lung injury by up-regulating SOCS3-mediated pathway
por: Peng, Chung-Kan, et al.
Publicado: (2019)

AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis
por: Goyette, Marie-Anne, et al.
Publicado: (2022)

AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies: Focus on Multiple Myeloma
por: Yan, Siyang, et al.
Publicado: (2019)

Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
por: Ekman, Carl, et al.
Publicado: (2011)

Effect of GAS6 and AXL Gene Polymorphisms on Adiposity, Systemic Inflammation, and Insulin Resistance in Adolescents
por: Hsiao, Fone-Ching, et al.
Publicado: (2014)

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma
por: Dantas-Barbosa, Carmela, et al.
Publicado: (2017)

Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
por: Yan, Dan, et al.
Publicado: (2021)

Collaboration Between RSK-EphA2 and Gas6-Axl RTK Signaling in Arginine Starvation Response That Confers Resistance to EGFR Inhibitors
por: Kuo, Macus Tien, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2si2086e8adehqh50078jm6vii